December 14, 2020

Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and
Recovery Fund and Reminds Shareholders about Annual General Meeting Today

November 26, 2020

Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest,
Consulting Fees and DSU Exercise

November 24, 2020

Ventripoint Annual General Meeting

January 4, 2021

Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis
System

Ventripoint Expands to Address the Needs of Companion Animals

January 11, 2021

December 15, 2020

Ventripoint Diagnostics Reports Results of Annual General & Special
Shareholders Meeting

Canada's Largest Cardiac Centre Receives VMS+ 3.0 Ventripoint Whole Heart Analysis System

November 5, 2020

Ventripoint Announces Appointment to the Board of Directors and Option
Grants

September 25, 2020

Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services

Ventripoint Remotely Installs Whole Heart Analysis System in Major European Hospital

Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020

September 23, 2020

Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading

September 15, 2020

Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement

September 14, 2020

September 15, 2020

Ventripoint Diagnostics Announces U.S. FDA Clearance for VMS+ 3.0 Whole Heart Analysis System

October 17, 2019

St. Michael's Hospital to Receive VMS+ 3.0 Whole Heart Analysis System

October 16, 2019